| CAM | Cell-adhesion molecule |
| CEAP | Clinical, Etiological, Anatomical, and Pathophysiological classification |
| COL-1/3 | Collagen-1/3 genes |
| COX | Cyclo-oxygenase |
| CVeD | Chronic venous disorders |
| CVI | Chronic venous insufficiency |
| EC | Endothelial cell |
| ECM | Extra-cellular matrix |
| FGF-2 | Fibroblast growth factor-2 |
| GAG | Glycosaminoglycan |
| GAGase | Glycosaminoglycanase |
| GF | Growth factor |
| HIF | Hypoxia-inducible factor |
| HO | Hemeoxygenase |
| IGF-1 | Insulin growth factor-1 |
| IL | Interleukin |
| KGF | Keratinocyte growth factor |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MMP | Matrix metalloproteinase |
| NO | Nitric oxide |
| NOS | Nitic oxide synthase |
| PAI-1 | Plasminogen-activator inhibitor-1 |
| PDGF-bb | Platelet derived growth factor-bb |
| PGI-2 | Prostaglandin I-2 |
| PMN | Polymorphonuclear cells |
| RNS | Reactive nitrous species |
| ROS | Reactive oxygen species |
| sENG | Soluble Endoglin |
| SMC | Smooth muscle cell |
| TGF-β | Transforming growth factor-beta |
| TIMP | Tissue inhibitor of metalloproteinase |
| TNF-α | Tumor necrosis factor-α |
| VEGF | Vascular endothelial growth factor |
| vWF | von Willebrand factor |